The addition of adjuvant nivolumab to standard-of-care radiotherapy and cisplatin improved survival for patients with locally ...

Felton's Robin Agar-Celli ships every hat herself, paying out of her own pocket. But it's the thousands of worldwide volunteers who fuel her dream.

Scientists have developed inhalable lung cancer therapeutics utilizing mucoadhesive proteinic nanoparticles.

Laura Leatherberry, a hairstylist and owner of Salon Renew in Viroqua, cuts and styles client Sue Melvin's hair about ...

Meanwhile, the National Institutes of Health says that research has shown higher rates of depression and increased risk for the disorder among LGBTQ+ patients. The AMA’s What Doctors Wish Patients ...

An effective immunotherapy would be life-changing for rectal cancer patients, with current treatments often resulting in a suite of negative outcomes in survivors, including loss of fertility and ...

Patients most "in need" should be able to see the same doctor at every appointment in their local GP surgery, the government says. GPs will be rewarded financially if they do this and if they go ...

I was struck by how similar his case was to that of another Weiner patient, Scot Warwick. Weiner had diagnosed Warwick with Stage 4 lung cancer and treated him with chemo and other therapies for 11 ...

Russia announced that it had developed an mRNA vaccine for cancer patients. The vaccine will be available from early 2025 and will be distributed for free. The vaccine will cost the Russian government ...

Andrey Kaprin, General Director of the Radiology Medical Research Center of the Russian Ministry of Health, told Radio Rossiya, “Russia has developed its own mRNA vaccine against cancer, it will be ...

In a significant medical breakthrough, Russia has reportedly developed an mRNA vaccine against cancer, which will be made available to patients free of cost by 2025. The announcement was made by ...

Russia has announced the development of a pioneering mRNA vaccine against cancer, promising free access to patients by early 2025. Russia has developed an mRNA-based vaccine targeting cancer ...